| Literature DB >> 30053980 |
Antonio Ruiz-García1, Ezequiel Arranz-Martínez2, Ignacio Morón-Merchante3, Vicente Pascual-Fuster4, Juan J Tamarit5, Ferran Trias-Villagut6, Xavier Pintó-Sala6, Juan F Ascaso7.
Abstract
A consensus document of the Diabetes working group of the Spanish Society of Arteriosclerosis (SEA) is presented, based on the latest studies and conceptual changes that have appeared. It presents the cardiovascular risk in type 2 diabetes mellitus (T2DM) and the action guidelines for the prevention and treatment of cardiovascular disease (CVD) associated with T2DM. The importance of lipid control, based on the objective of LDL-C and non-HDL-C when there is hypertriglyceridemia, and the blood pressure control in the prevention and treatment of CVD is evaluated. The new hypoglycemic drugs and their effects on CVD are reviewed, as well as the treatment and control guidelines of hyperglycemia. Likewise, the use of antiplatelet agents is considered. Emphasis is placed on the importance of global and simultaneous action on all risk factors to achieve a significant reduction in cardiovascular events. This supplement is sponsored by Laboratorios Esteve, S.A.Entities:
Keywords: Antiagregantes; Antiplatelet agents; Cardiovascular disease; Cardiovascular risk; Diabetes tipo 2; Dislipidemia; Dyslipidemia; Enfermedad cardiovascular; Hipertensión arterial; Hypertension; Riesgo cardiovascular; Type 2 diabetes
Mesh：
Substances：
Year: 2018 PMID： 30053980 DOI： 10.1016/j.arteri.2018.06.006
Source DB: PubMed Journal: Clin Investig Arterioscler ISSN： 0214-9168